The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Nampt: linking NAD biology, metabolism and cancer
Open accessAbstract
Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to nicotinamide mononucleotide (NMN), a key NAD intermediate. Previously identified as a cytokine PBEF and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in different fields, including NAD biology, metabolism, and inflammation. As an NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses. Nampt also plays an important role in the regulation of insulin secretion in pancreatic β cells. Nampt appears to have another function as an immunomodulatory cytokine and plays a role in inflammation. This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedFukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
RetractedTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Self-citationPoirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253 · cited 1×
“Silent information regulator 2 (Sir2), as the prototypical enzyme of this group, regulates the replicative life span of yeast mother cells[48].”
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 1×
“Because sirtuins have recently emerged as promising pharmaceutical targets to develop therapeutic interventions against age-associated diseases[59,60], the systemic enhancement of NAD biosynthesis might provide another pharmacological means to activate Sirt1 and to convey benefits against age-associated diseases[61].”
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
The Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495
Sir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010
Self-citationNutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950 · cited 5×
“In conclusion, Nampt-mediated NAD biosynthesis influences cellular differentiation, stress resistance, and metabolic responses in different cell types by raising intracellular NAD levels and thereby regulating the activity of NAD-consuming enzymes such as sirtuins and PARPs [12,52,13,53,55,54].”
InfluentialVisfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
Moschen, A. R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., & Tilg, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1748 · Cited by 933
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Self-citationFulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., & Sartorelli, V. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.004 · Cited by 820
Plasma Visfatin Concentrations and Fat Depot–Specific mRNA Expression in Humans
Berndt, J., Klöting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schön, M. R., Stumvoll, M., & Blüher, M. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2911 · Cited by 724
Chen, M.-P., Chung, F.-M., Chang, D.-M., Tsai, J. C.-R., Huang, H.-F., Shin, S.-J., & Lee, Y.-J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1475 · Cited by 660
Moynihan, K. A., Grimm, A. A., Plueger, M. M., Bernal-Mizrachi, E., Ford, E., Cras-Méneur, C., Permutt, M. A., & Imai, S.-I. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.001 · Cited by 628
Self-citationMenissier de Murcia, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg206 · Cited by 627
Hasmann, M., & Schemainda, I. (2003) · PubMed · Cited by 617
Jia, S. H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O. D., & Marshall, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19930 · Cited by 598
Obesity as a cardiovascular risk factor
Sowers, J. R. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.012 · Cited by 584 · cited 1×
“In the pathophysiology of obesity and T2DM, it has been revealed that chronic inflammation plays an important role in the development of insulin resistance and other associated complications, such as atherosclerosis[39,40,41,42].”
Rongvaux, A., Shea, R. J., Mulks, M. H., Gigot, D., Urbain, J., Leo, O., & Andris, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3225::aid-immu3225>3.0.co;2-l · Cited by 548
Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease
Lin, S.-J., & Guarente, L. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00006-1 · Cited by 476
Dahl, T. B., Yndestad, A., Skjelland, M., Øie, E., Dahl, A., Michelsen, A., Damås, J. K., Tunheim, S. H., Ueland, T., Smith, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.665893 · Cited by 465
Adya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm111 · Cited by 437
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers
Lee, H. C. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.317 · Cited by 433
Conserved Metabolic Regulatory Functions of Sirtuins
Schwer, B., & Verdin, E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.006 · Cited by 415
Pillai, J. B., Isbatan, A., Imai, S.-I., & Gupta, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506162200 · Cited by 391
Self-citationCheng, K.-H., Chu, C.-S., Lee, K.-T., Lin, T.-H., Hsieh, C.-C., Chiu, C.-C., Voon, W.-C., Sheu, S.-H., & Lai, W.-T. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803726 · Cited by 362
Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase
van der Veer, E., Ho, C., O'Neil, C., Barbosa, N., Scott, R., Cregan, S. P., & Pickering, J. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700018200 · Cited by 325
Ramsey, K. M., Mills, K. F., Satoh, A., & Imai, S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00355.x · Cited by 321
Self-citationThe regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801b3c8f · Cited by 310
Self-citationStructure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
Wang, T., Zhang, X., Bheda, P., Revollo, J. R., Imai, S.-I., & Wolberger, C. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1114 · Cited by 302
Self-citationPre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
Luk, T., Malam, Z., & Marshall, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807581 · Cited by 302
Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G., & Vettor, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0361 · Cited by 295
NEW EMBO MEMBER'S REVIEW: Functional aspects of protein mono-ADP-ribosylation
Corda, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg209 · Cited by 294
Reconstructing eukaryotic NAD metabolism
Rongvaux, A., Andris, F., Van Gool, F., & Leo, O. (2003) · BioEssays · doi:10.1002/bies.10297 · Cited by 280
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
Khan, J. A., Tao, X., & Tong, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1105 · Cited by 262
Ognjanovic, S., Bao, S., Yamamoto, S., Garibay-Tupas, J., Samal, B., & Bryant-Greenwood, G. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260107 · Cited by 257
Busso, N., Karababa, M., Nobile, M., Rolaz, A., Van Gool, F., Galli, M., Leo, O., So, A., & De Smedt, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002267 · Cited by 243
Magni, G., Amici, A., Emanuelli, M., Raffaelli, N., & Ruggieri, S. (1999) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123195.ch5 · Cited by 235
Insulin-Like Effects of Visfatin on Human Osteoblasts
Xie, H., Tang, S.-Y., Luo, X.-H., Huang, J., Cui, R.-R., Yuan, L.-Q., Zhou, H.-D., Wu, X.-P., & Liao, E.-Y. (2007) · Calcified Tissue International · doi:10.1007/s00223-006-0155-7 · Cited by 231
Li, Y., Zhang, Y., Dorweiler, B., Cui, D., Wang, T., Woo, C. W., Brunkan, C. S., Wolberger, C., Imai, S.-I., & Tabas, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805866200 · Cited by 211
Self-citationENZYMATIC SYNTHESIS OF NICOTINAMIDE MONONUCLEOTIDE
Preiss, J., & Handler, P. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64875-6 · Cited by 207
Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes
Ognjanovic, S., & Bryant-Greenwood, G. D. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126295 · Cited by 191
van der Veer, E., Nong, Z., O’Neil, C., Urquhart, B., Freeman, D., & Pickering, J. G. (2005) · Circulation Research · doi:10.1161/01.res.0000173298.38808.27 · Cited by 187
Hug, C., & Lodish, H. F. (2005) · Science · doi:10.1126/science.1106933 · Cited by 180
A therapeutic role for sirtuins in diseases of aging?
WESTPHAL, C., DIPP, M., & GUARENTE, L. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.008 · Cited by 168
(1986) · Journal of Gerontology · doi:10.1093/geronj/41.5.685b · Cited by 167
Szopa, M., & Dembinska-Kiec, A. (2005) · Jagiellonian University Repository (Jagiellonian University) · Cited by 166
Identification of a Plasmid-Encoded Gene from Haemophilus ducreyi Which Confers NAD Independence
Martin, P. R., Shea, R. J., & Mulks, M. H. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1168-1174.2001 · Cited by 165
Hufton, S. E., Moerkerk, P. T., Brandwijk, R., de Bruïne, A. P., Arends, J.-W., & Hoogenboom, H. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01578-1 · Cited by 164
Calorie restriction and SIR2 genes—Towards a mechanism
Guarente, L. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.03.013 · Cited by 162
Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays
Körner, A., Garten, A., Blüher, M., Tauscher, R., Kratzsch, J., & Kiess, W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1304 · Cited by 159
Self-citationVisfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Kim, S.-R., Bae, S., Choi, K., Park, S.-Y., Jun, H. O., Lee, J. Y., Jang, H., Yun, I., Yoon, K., Kim, Y.-J., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.105 · Cited by 156
Nuclear Factor-κB Induction by Visfatin in Human Vascular Endothelial Cells
Adya, R., Tan, B. K., Chen, J., & Randeva, H. S. (2008) · Diabetes Care · doi:10.2337/dc07-1544 · Cited by 149
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
Choi, K. M., Lee, J. S., Kim, E. J., Baik, S. H., Seo, H. S., Cho, Y., Oh, D. J., & Park, C. G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0633 · Cited by 141
Peng, X.-D., Xie, H., Zhao, Q., Wu, X., Sun, Z., & Liao, E.-Y. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.08.012 · Cited by 139
B, J. R. V. B., Moerkerk, P. T. M., Gerbers, A. J., A, A. P. D. B., Arends, J., Hoogenboom, H. R., & Hufton, S. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10584 · Cited by 134
Anticancer agent CHS-828 inhibits cellular synthesis of NAD
Olesen, U. H., Christensen, M. K., Björkling, F., Jäättelä, M., Jensen, P. B., Sehested, M., & Nielsen, S. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.019 · Cited by 126
Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway
Tanaka, M., 野崎, 真., Fukuhara, A., Segawa, K., Aoki, N., Matsuda, M., Komuro, R., & Shimomura, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.096 · Cited by 123
Kim, M., Lee, J. H., Kim, H., Park, S.-J., Kim, S. H., Kang, G. B., Lee, Y. S., Kim, J. B., Kim, K. K., Suh, S. W., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.082 · Cited by 122
Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity?
Yang, H., Lavu, S., & Sinclair, D. A. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.003 · Cited by 114
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
Song, H. K., Lee, M., Kim, B. K., Park, Y. G., Ko, G. J., Kang, Y. S., Han, J., Han, S. Y., Han, K. H., Kim, H. K., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90231.2008 · Cited by 114
Stephens, J. M., & Vidal-Puig, A. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217893.77746.4b · Cited by 113
Effect of exercise training on plasma visfatin and eotaxin levels
Choi, K. M., Kim, J. H., Cho, G. J., Baik, S. H., Park, H. S., & Kim, S. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0127 · Cited by 112
Yılmaz, M. İ., Sağlam, M., Qureshi, A. R., Carrero, J. J., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Oğuz, Y., Vural, A., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm828 · Cited by 111
The implication of proinflammatory cytokines in type 2 diabetes
Christopher, B. G. (2008) · Frontiers in bioscience · doi:10.2741/3074 · Cited by 109
Nazar, R. N., & Robb, E. J. (2007) · Science · doi:10.1126/science.318.5850.565c · Cited by 109
Editorial: Visfatin—A True Or False Trail To Type 2 Diabetes Mellitus
Arner, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2391 · Cited by 106
Ravaud, A., Cerny, T., Terret, C., Wanders, J., Bui, B., Hess, D., Droz, J., Fumoleau, P., & Twelves, C. J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.023 · Cited by 105
Muruganandham, M., Alfieri, A. A., Matei, C., Chen, Y., Sukenick, G. D., Schemainda, I., Hasmann, M., Saltz, L. B., & Koutcher, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1399 · Cited by 89
Serum levels of the adipokine visfatin are increased in pre‐eclampsia
Faßhauer, M., Waldeyer, T., Seeger, J., Schrey-Petersen, S., Ebert, T., Kratzsch, J., Lössner, U., Blüher, M., Stümvoll, M., Faber, R., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03147.x · Cited by 88
Woodhead, A. D., Blackett, A. D., & Hollaender, A. (1985) · Springer eBooks · doi:10.1007/978-1-4899-2218-2 · Cited by 84
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Imai, S., & Kiess, W. (2009) · Frontiers in bioscience · doi:10.2741/3428 · Cited by 84
Self-citationJin, H., Jiang, B., Tang, J., Lu, W., Wang, W., Zhou, L., Shang, W., Li, F., Ma, Q., Yang, Y., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.019 · Cited by 84
Malavazos, A. E., Ermetici, F., Cereda, E., Coman, C., Locati, M., Morricone, L. F., Romanelli, M. M. C., & Ambrosi, B. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.09.001 · Cited by 83
Retnakaran, R. R., Youn, B., Liu, Y., Hanley, A. J., Lee, N. S., Park, J. W., Song, E. S., Vu, V. P., Kim, W. I., Tungtrongchitr, R., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03264.x · Cited by 82
Bailey, S. D., Loredo‐Osti, J. C., Lepage, P., Faith, J., Fontaine, J., Desbiens, K., Hudson, T. J., Bouchard, C., Gaudet, D., Përusse, L., et al. (2006) · Diabetes · doi:10.2337/db06-0189 · Cited by 78
Chen, C., Li, T., Li, C.-I., Liu, C.-S., Lin, W., Wu, M., Lai, M.-M., & Lin, C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.018 · Cited by 77
Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1
Xu, L., Wu, M., Hu, J., Zhai, Z., & Shu, H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.410 · Cited by 70
Plasma Visfatin Concentration as a Surrogate Marker for Visceral Fat Accumulation in Obese Children
Araki, S., Dobashi, K., Kubo, K., Kawagoe, R., Yamamoto, Y., Kawada, Y., Asayama, K., & Shirahata, A. (2008) · Obesity · doi:10.1038/oby.2007.54 · Cited by 70
The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile
Wang, P., van Greevenbroek, M. M. J., Bouwman, F. G., Brouwers, M. C. G. J., Kallen, C., Smit, E., Keijer, J., & Mariman, E. C. M. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0262-y · Cited by 68
Drevs, J., Löser, R., Rattel, B., & Esser, N. (2003) · PubMed · Cited by 65
Pogrebniak, A., Schemainda, I., Azzam, K., Pelka‐Fleischer, R., Nuessler, V., & Hasmann, M. (2006) · PubMed · Cited by 61
Visfatin/pre-B-cell colony-enhancing factor: A protein with various suggested functions
Pilz, S., Mangge, H., Obermayer-Pietsch, B. M., & März, W. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347412 · Cited by 57
Plasma Visfatin Concentrations in Severely Obese Subjects Are Increased After Intestinal Bypass
García‐Fuentes, E., García‐Almeida, J. M., García-Arnés, J. A., García‐Serrano, S., Rivas-Marín, J., Gallego-Perales, J. L., Rojo‐Martínez, G., Garrido‐Sánchez, L., Bermúdez‐Silva, F. J., de Fonseca, F. R., et al. (2007) · Obesity · doi:10.1038/oby.2007.284 · Cited by 54
Kendal‐Wright, C. E., Hubbard, D., & Bryant-Greenwood, G. D. (2008) · Placenta · doi:10.1016/j.placenta.2007.12.008 · Cited by 50
Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?
Sethi, J. K. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0007-5 · Cited by 43
Alghasham, A., & Barakat, Y. A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4217 · Cited by 40
Seo, J. A., Jang, E. S., Kim, B. G., Ryu, O. H., Kim, H. Y., Lee, K. W., Kim, S. G., Choi, K. M., Baik, S. H., Cho, Y., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.016 · Cited by 38
Preanalytical influences on the measurement of visfatin by enzyme immuno assay
Nüsken, K., Nüsken, E., Petrasch, M., Rauh, M., & Dötsch, J. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.004 · Cited by 34
Is Sirt1 a miracle bullet for longevity?
Imai, S. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00344.x · Cited by 17
Self-citation
Cited by
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
Maury, E., & Brichard, S. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.031 · Cited by 1,026
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
“In several cell models, FK866 showed great promise by depleting NAD levels and thereby influencing not only tumorigenesis, but also metastasis and angiogenesis (31, 184).”
Background
Metadata
- Authors
- Garten, A., Petzold, S., Körner, A., Imai, S.-I., & Kiess, W.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 20
- Issue
- 3
- Pages
- 130-138
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2092950801
- Cited by
- 398
- References
- 96
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.